TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 176 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,769,642 | +113.5% | 441,019 | +212.7% | 2.06% | +132.9% |
| Q1 2023 | $3,170,107 | -60.2% | 141,019 | -62.8% | 0.88% | -64.0% |
| Q4 2022 | $7,963,189 | +73.8% | 379,019 | +103.8% | 2.46% | +67.4% |
| Q3 2022 | $4,582,000 | -98.8% | 186,019 | +1918.7% | 1.47% | -62.9% |
| Q2 2022 | $380,000,000 | +24416.1% | 9,215 | -97.6% | 3.96% | +1032.6% |
| Q1 2022 | $1,550,000 | -86.9% | 380,000 | 0.0% | 0.35% | -86.7% |
| Q4 2021 | $11,803,000 | +28.1% | 380,000 | 0.0% | 2.63% | +18.3% |
| Q3 2021 | $9,215,000 | +3055.8% | 380,000 | +1800.0% | 2.22% | +2787.0% |
| Q2 2021 | $292,000 | -41.5% | 20,000 | 0.0% | 0.08% | -41.7% |
| Q1 2021 | $499,000 | -8.4% | 20,000 | 0.0% | 0.13% | -11.4% |
| Q4 2020 | $545,000 | – | 20,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |